Assignment of Assignor's Interest

Recorded: 2026-04-28 Pages: 8

Assignor

LUNG THERAPEUTICS, LLC

Executed: 2025-02-28

Assignee

REIN THERAPEUTICS, INC.

12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TEXAS, 78758

Covered Property (1)

Modified Peptide Fragments of Cav-1 Protein and the Use Thereof in the Treatment of Fibrosis

Application: 19/388,100 →

Publication: US 2026/0062444

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.